Provided herein are novel piperazine compounds acting as selective serotonin reuptake inhibitors and/or the 5-HT1A receptor agonists. The invention also relates to the methods of preparing the compound and pharmaceutical composition, and the use of treating central nervous system dysfunction in mammals especially in humans.
本文提供了作为选择性
血清素再摄取
抑制剂和/或5-HT1A受体激动剂的新型
哌嗪化合物。该发明还涉及制备该化合物和药物组合物的方法,以及用于治疗哺乳动物中枢神经系统功能障碍,特别是人类的用途。